Certified by Founder Lodge
LabGenius
United Kingdom - London, UK
START UP
1 Disclosed Funding Rounds $44,609,250
0 Participating Investments
-
Founded date
2012
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
LabGenius is the first biopharmaceutical company developing next generation protein therapeutics using a machine learning-driven evolution engine (EVA™).
Our protein engineering platform i
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| May, 22 ,2024 | Series B | $44,609,250 |
Octopus Ventures
Kindred Capital VC
Atomico
Obvious Ventures
M Ventures(Netherlands)
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Clairity, Inc. | $43,000,000 | (Nov 14, 2025)
Songscription | $5,000,000 | (Nov 14, 2025)
Park Loyalty | Undisclosed Amount | (Nov 14, 2025)
Carbon(US) | $60,000,000 | (Nov 14, 2025)
CoRun.ai | $3,500,000 | (Nov 14, 2025)
